In July of 2021, the Company received FDA 510(K) clearance to market and sell Alma Hybrid and Class I medical device registration of Alma TED in January of 2022.

Alma Hybrid and Alma TED systems are now commercially available in Canada, the company reports.

Alma Hybrid, the first laser platform to include an ablative 10,600 nm (CO2) laser and a non-ablative 1570 nm laser for skin resurfacing that offers a comprehensive solution to utilize each best-in-class laser independently or for the very first time, customizes the treatment pattern by combining both wavelengths.

Alma TED, an ultrasound-based system engineered to deliver acoustic soundwaves combined with a proprietary Tip to deliver air pressure for aesthetic applications

In July of 2021, the Company received FDA 510(K) clearance to market and sell Alma Hybrid and Class I medical device registration of Alma TED in January of 2022.

"Regulatory clearances remain a critical milestone in our North America commercial launch strategy because it strengthens and diversifies our products to include key markets like Canada," says Keith Adams, President of Alma, North America, in a news release. "We're excited to offer innovative energy-based solutions and revenue opportunities, like Alma Hybrid and Alma TED, to our providers throughout Canada as we look towards continuing our growth and expanding our footprint into this market." 

Alma launched Alma TED along with the CBD+ Professional Skincare Solution at the  American Academy of Dermatology Annual Meeting in Boston.